Cases of individuals with MDS have been ascertained alongside individuals with a MECP2 mutation in the InterRett [19], thus forming an important platform for our development of the international MECP2 Duplication Database (MDBase) in 2020. Here, MECP2 is linked to myelodysplastic syndrome.